28-Day Faster Diagnosis

Identifying Attributes

Care Settings
Care Transitions
Country
England
Publishing Organisation
National Health Service (NHS) England: Cancer Waiting Times
Type of Quality Indicator
Process
IOM Quality Dimension
Timeliness
Domain
Access / Waiting Times

Defining Attributes

Definition

Percentage of people told by a specialist if they had cancer, or if cancer was definitively excluded, within four weeks (28-days) of an urgent referral.

Numerator

Number of people told their cancer diagnosis outcome within 28 days (all referral routes). Clock start: Receipt of the referral by the provider who will first see the patient (day zero). Clock end: Date of direct communication of the diagnosis with the patient either face to face/via phone/Skype or email or letter sent date/ date of communication by primary care provider.

Denominator

Total number of people told cancer diagnosis outcome (all referral routes).

Exclusions

Patients who died before a communication of diagnosis; declined all diagnostic appointments; declined all appointments; opted for private diagnostics; Repeated Did Not Attends (DNAs)/Patient triggered cancellations; Patients ineligible for NHS funded care.

Use of Risk Adjustment
No
Risk Adjustments
Stratifications

Data Attributes

Type of Data Collection
Administrative data
Data Collection Methods

The National Cancer Waiting Times Monitoring Data Set requires the submission of data to monitor NHS providers' compliance with the government's operational standards for ensuring that cancer services (diagnosis and treatment) are delivered to patients in a timely manner.

Frequency of Data Collection
Monthly
Frequency of Data Collection in Days
30
Reporting Methods

NHS Cancer Waiting Times website.

Reporting Frequency
Monthly
Reporting Frequency in Days
30
Indicator Has Recommended Targets
Yes

Source and Reference Attributes

Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
12 March 2025